表位
中和抗体
抗体
人类免疫缺陷病毒(HIV)
病毒学
生物
顶点(几何体)
免疫学
解剖
作者
M. Krystal,Henry J. Sutton,Payal Pratap,Jon M. Steichen,Diane G. Carnathan,James C. Quinn,Oleksandr Kalyuzhniy,Alessia Liguori,Sashank Agrawal,Sabyasachi Baboo,Patrick Madden,Christopher A. Cottrell,Jordan R. Willis,Jeong Hyun Lee,Elise Landais,Xiaozhen Hu,Parham Ramezani-Rad,Gabriel Ozorowski,Vanessa Lewis,Jolene K. Diedrich
出处
期刊:Science immunology
[American Association for the Advancement of Science]
日期:2025-08-22
卷期号:10 (110): eadt6660-eadt6660
被引量:3
标识
DOI:10.1126/sciimmunol.adt6660
摘要
An effective prophylactic HIV vaccine will likely need to induce broadly neutralizing antibodies (bnAbs). bnAbs to the Apex region of the HIV envelope glycoprotein (Env) are promising targets for vaccination because of their relatively low somatic hypermutation compared with other bnAbs. Most Apex bnAbs engage Env using an exceptionally long heavy-chain complementarity-determining region 3 (HCDR3) containing specific binding motifs, which reduces bnAb precursor frequency and makes priming of rare bnAb precursors a likely limiting step in the path to Apex bnAb induction. We found that adjuvanted protein or mRNA lipid nanoparticle (LNP) immunization of rhesus macaques with ApexGT6, an Env trimer engineered to bind Apex bnAb precursors, consistently induced Apex bnAb–related precursors with long HCDR3s bearing bnAb-like sequence motifs. Cryo–electron microscopy revealed that elicited Apex bnAb–related HCDR3s had structures combining elements of several prototype Apex bnAbs. These results achieve a critical HIV vaccine development milestone in outbred primates.
科研通智能强力驱动
Strongly Powered by AbleSci AI